A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes

Cancer Research

Volumn 67, Issue 19, 2007, Pages 9528-9534

  Koslowski, Michael ^a   Sahin, Ugur ^a   Mitnacht Kraus, Rita ^b   Seitz, Gerhard ^c   Huber, Christoph ^a   Türeci, Özlem ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Ganymed Pharmaceuticals AG   (Germany)

^c Sozialstiftung Bamberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GENE PRODUCT; PLAC1 PROTEIN; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER INVASION; CELL CYCLE ARREST; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE; PLAC1 GENE; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION; TUMOR GENE; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PREGNANCY PROTEINS; RNA, SMALL INTERFERING;

EID: 35148891213     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1350     Document Type: Article

References (43)

1. Adams GP, Weiner LM. Monoclonal antibody therapy of cancer. Nat Biotechnol 2005;23:1147-57.
2. Brekke OH, Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2003;2:52-62.
3. Carter P. Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001;1:118-29.
4. Houshmand P, Zlotnik A. Targeting tumor cells. Curr Opin Cell Biol 2003;15:640-4.
5. Beard J. Embryological aspects and etiology of carcinoma. Lancet 1902;1:1758-63.
6. Gurchot C. The trophoblast theory of cancer revisited. Oncology 1975;31:310-3.
7. Acevedo HF, Tong JY, Hartsock RJ. Human chorionic gonadotropin-β subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 1995;76:1467-75.
8. Dirnhofer S, Koessler P, Ensinger C, Feichtinger H, Madersbacher S, Berger P. Production of trophoblastic hormones by transitional cell carcinoma of the bladder: association to tumor stage and grade. Hum Pathol 1998;29:377-82.
9. Iles RK, Chard T. Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential. J Urol 1991;145:453-8.
10. Laurence DJ, Neville AM. Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br J Cancer 1972;26:335-55.
11. Koslowski M, Bell C, Seitz G, et al. Frequent nonrandom activation of germ-line genes in human cancer. Cancer Res 2004;64:5988-93.
12. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005;5:615-25.
13. Koslowski M, Sahin U, Huber C, Tureci O. The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes. Hum Mol Genet 2006;15:2392-9.
14. Koslowski M, Tureci O, Bell C, et al. Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res 2002;62:6750-5.
15. Scheurle D, DeYoung MP, Binninger DM, Page H, Jahanzeb M, Narayanan R. Cancer gene discovery using digital differential display. Cancer Res 2000;60:4037-43.
16. Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000;16:276-7.
17. Jones DT, Taylor WR, Thornton JM. A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 1994;33:3038-49.
18. Hofmann K, Stoffel W. TMbase - A databse of membrane spanning protein segments. Biol Chem Hoppe-Seyler 1993;374:166.
19. Garnier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol 1978;120:97-120.
20. Fant M, Weisoly DL, Cocchia M, et al. PLAC1, a trophoblast-specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factor. Mol Reprod Dev 2002;63:430-6.
21. Cocchia M, Huber R, Pantano S, et al. PLAC1, an Xq26 gene with placenta-specific expression. Genomics 2000;68:305-12.
22. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci US A 1996;93:7149-53.
23. De Smet C, Lurquin C, Lethe B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999;19:7327-35.
24. Honda T, Tamura G, Waki T, et al. Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer 2004;90:838-43.
25. Bork P, Sander C. A large domain common to sperm receptors (Zp2 and Zp3) and TGF-β type III receptor. FEBS Lett 1992;300:237-40.
26. Jovine L, Janssen WG, Litscher ES, Wassarman PM. The PLAC1-homology region of the ZP domain is sufficient for protein polymerisation. BMC Biochem 2006;7:11.
27. Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997;13:261-91.
28. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000;60:3689-95.
29. Caldon CE, Daly RJ, Sutherland RL, Musgrove EA. Cell cycle control in breast cancer cells. J Cell Biochem 2006;97:261-74.
30. Sutherland RL, Musgrove EA. Cyclins and breast cancer. J Mammary Gland Biol Neoplasia 2004;9:95-104.
31. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-65.
32. D'Amico M, Hulit J, Amanatullah DF, et al. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3β and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 2000;275:32649-57.
33. Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 1998;273:29864-72.
34. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998;12:3499-511.
35. Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu MM. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol 2003;23:6139-49.
36. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-7.
37. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 2003;4:257-62.
38. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-12.
39. Massabbal E, Parveen S, Weisoly DL, Nelson DM, Smith SD, Fant M. PLAC1 expression increases during trophoblast differentiation: evidence for regulatory interactions with the fibroblast growth factor-7 (FGF-7) axis. Mol Reprod Dev 2005;71:299-304.
40. Attisano L, Wrana JL, Lopez-Casillas F, Massague J. TGF-β receptors and actions. Biochim Biophys Acta 1994;1222:71-80.
41. Derynck R, Feng XH. TGF-β receptor signaling. Biochim Biophys Acta 1997;1333:105-50.
42. Sexton PM, Albiston A, Morfis M, Tilakaratne N. Receptor activity modifying proteins. Cell Signal 2001;13: 73-83.
43. Udawela M, Hay DL, Sexton PM. The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin Cell Dev Biol 2004;15:299-308.